Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-11 Purchase | 2020-08-12 9:04 pm | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 133,333 | $15 | $1,999,995 | 3,606,707 (Indirect) | View |
| 2020-06-01 Sale | 2020-06-03 8:20 pm | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 500,000 | $1.6242 | $812,080 | 1,226,514 (Direct) | View |
| 2019-11-15 Purchase | 2019-11-19 9:47 pm | NextCure Inc. | NXTC | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 150,000 | $36.75 | $5,512,500 | 2,671,856 (Direct) | View |
| 2019-11-12 Purchase | 2019-11-12 4:17 pm | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 750,000 | $12 | $9,000,000 | 3,083,712 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-08-11 Conversion | 2020-08-12 9:04 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 28,371,348 | $0 | 3,606,707 (Indirect) | View |
Ownership | 2020-08-06 9:12 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 0 | $0 | 3,473,374 (Indirect) | View |
| 2020-01-21 Option Award | 2020-01-23 7:25 pm | N/A 2025-01-31 | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL 10% Owner | 1,750,000 | $1,750,000 | 1,750,000 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-12 4:17 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 14,134,280 | $0 | 3,083,712 (Direct) | View |
Ownership | 2019-11-06 5:22 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 0 | $0 | 2,333,712 (Direct) | View |